Stay updated on GB5121 in Refractory CNS Lymphoma Clinical Trial

Sign up to get notified when there's something new on the GB5121 in Refractory CNS Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GB5121 in Refractory CNS Lymphoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The sponsor entity name was updated to Gossamer Bio USA, Inc. (GB005, Inc.), and the page revision progressed from v3.6.3 to v3.6.4.
    Difference
    0.2%
    Check dated 2026-07-25T06:46:01.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.3 in place of Revision: v3.6.2, indicating an update to the interface version. This is a UI/versioning change and does not alter the study data or its presentation beyond the version label.
    Difference
    0.1%
    Check dated 2026-07-03T21:53:46.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The page now shows a new revision tag indicating v3.6.2, updating the page's version label. This reflects an internal update to the page template rather than changes to study data or content.
    Difference
    0.1%
    Check dated 2026-06-26T23:26:04.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    Recruitment status is now shown as 'No longer looking for participants', indicating the study is not enrolling. The page also adds new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention label from 'Intervention / Treatment' to 'Intervention/Treatment' with a revision tag updated to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-12T16:04:21.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    The page shows a revision label updated from v3.5.4 to v3.5.5, indicating a newer page template version. This is a technical update and does not modify study details, eligibility criteria, results, or other substantive content.
    Difference
    0.1%
    Check dated 2026-06-05T10:10:58.000Z thumbnail image
  9. Check
    82 days ago
    Change Detected
    Summary
    Revision updated from v3.5.3 to v3.5.4, indicating a minor platform update. There are no changes to study content or user-facing features described on the page.
    Difference
    0.1%
    Check dated 2026-05-15T04:21:48.000Z thumbnail image

Stay in the know with updates to GB5121 in Refractory CNS Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GB5121 in Refractory CNS Lymphoma Clinical Trial page.